Kanoria Chemicals & Industries Reports Significant Profit Decline in Q1 FY26
The substantial decrease in profitability and EPS, both on a standalone and consolidated basis, is a material negative development that is likely to have a high impact on investor perception and the company's stock performance.
The company reported a significant year-over-year decline in both standalone and consolidated net profit after tax and Earnings Per Share (EPS) for the quarter ended June 30, 2025, despite a slight increase in standalone total income.
* Kanoria Chemicals & Industries Limited announced its unaudited financial results for the first quarter ended 30 June 2025, approved by the Board of Directors on 5 August 2025. * For the standalone results, the total income for Q1 FY26 was ₹38.75 crore, a slight increase from ₹37.45 crore in Q1 FY25. However, the net profit after tax significantly decreased to ₹2.57 crore in Q1 FY26 from ₹4.31 crore in Q1 FY25. Basic and diluted Earnings Per Share (EPS) also fell to ₹2.29 from ₹3.96 during the same period. * In consolidated results, the total income for Q1 FY26 was ₹18.99 crore, a decrease compared to ₹24.78 crore in Q1 FY25. The net profit after tax declined to ₹1.90 crore in Q1 FY26 from ₹3.08 crore in Q1 FY25. Consolidated EPS was ₹1.94, down from ₹3.16 in Q1 FY25.
What to do with a filing like this
Kanoria Chemicals & Industries Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kanoria Chemicals & Industries Limited. Read the original for the full detail.